KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) Cost of Revenue (2016 - 2025)

CareDx's Cost of Revenue history spans 13 years, with the latest figure at $30.9 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 44.9% year-over-year to $30.9 million; the TTM value through Dec 2025 reached $102.6 million, up 25.21%, while the annual FY2025 figure was $102.6 million, 25.21% up from the prior year.
  • Cost of Revenue for Q4 2025 was $30.9 million at CareDx, up from $24.4 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $30.9 million in Q4 2025 and bottomed at $15.5 million in Q1 2021.
  • The 5-year median for Cost of Revenue is $21.5 million (2021), against an average of $22.1 million.
  • The largest annual shift saw Cost of Revenue surged 61.52% in 2021 before it dropped 19.74% in 2023.
  • A 5-year view of Cost of Revenue shows it stood at $20.8 million in 2021, then rose by 13.66% to $23.7 million in 2022, then fell by 12.43% to $20.7 million in 2023, then grew by 2.96% to $21.3 million in 2024, then skyrocketed by 44.9% to $30.9 million in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Cost of Revenue are $30.9 million (Q4 2025), $24.4 million (Q3 2025), and $24.3 million (Q2 2025).